Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5841 Journals

4873 Congresses

10700+ Unique Records

Diabetes Technology and Obesity Medicine

Electronic ISSN

2998-6702

Therapeutic Area

Artificial Intelligence, Behavioral Health Services, Diabetology, Diagnostic Medicine, Diagnostics/Diagnostic Testing, Endocrinology/Metabolism, Medical Instrumentation/Medical Devices, Obesity, Patient Safety, Pharmacology, Research, Telemedicine/Telehealth

Readership

Artificial Intelligence Researcher, Diabetologists, Endocrinologists, Family Practice Physicians, Health Professionals, Health Scientists, Healthcare Executives, Nurse Practitioners, Nurse Practitioners/Physician Assistants, Patient Advocates, Pediatricians, Pharmacologists, Researchers, Scientists, Scientists - Research/Biomedical Aging

Scope

Diabetes Technology and Obesity Medicine is an international peer-reviewed open access journal dedicated to revolutionizing diabetes and obesity management using advanced technologies, innovative therapeutic strategies, and the integration of artificial intelligence (AI). Our mission is to equip healthcare professionals with cutting-edge insights into emerging devices, advanced pharmacological treatments, innovative drug delivery systems, and state-of-the-art software solutions, including AI-driven tools related to diabetes and obesity. Each volume of this OA journal explores groundbreaking research and its practical applications in clinical settings, aiming to bridge the gap between scientific discovery and clinical practice. By promoting a multidisciplinary approach and leveraging AI for improved diagnostic accuracy, personalized treatment plans, and enhanced patient monitoring, we aim to redefine excellence in diabetes and obesity care, ultimately improving patient outcomes and quality of life. Diabetes Technology and Obesity Medicine covers the following topics: Advanced diagnostic and therapeutic tools for diabetes and obesity; Integration of artificial intelligence in patient monitoring and management; Innovative pharmacological treatments and drug delivery systems; Emerging technologies in diabetes care, such as: Continuous glucose monitoring systems (CGM), Automatic Insulin Delivery Systems (AID), Alternate insulin delivery methods, AI-driven predictive analytics for personalized treatment; Breakthrough therapeutic strategies for obesity management: Emerging GLP analogs and Novel drug targets and therapeutics; Behavioral and lifestyle interventions for diabetes and obesity; Telemedicine and remote patient management solutions; Complications associated with diabetes and obesity; Prevention and management of diabetes-related complications: Cutting-edge software solutions for diabetes and obesity care, Gestational diabetes, pregnancy associated with obesity, Research on new insulins and other medications with rapid onset of action, Strategies for the detection and prevention of hypoglycemia, and Pediatric diabetes and obesity care, including specialized treatments and technologies.

Sponsoring Association(s)

No associations affiliated with this journal

Publisher Name

Mary Ann Liebert, Inc.

To see more details about Diabetes Technology and Obesity Medicine, Subscribe Now!

Frequency Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
	– Kait G Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
	– Michael K. Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
	- Weill Cornell Medical Library

Journals ● Congresses ● Associations

Privacy Policy ● Terms of Service ● Glossary ● Contact Us